IMCR
Immunocore Holdings Ltd
NASDAQ: IMCR · HEALTHCARE · BIOTECHNOLOGY
$27.92
-3.02% today
Updated 2026-04-29
Market cap
$1.42B
P/E ratio
—
P/S ratio
3.55x
EPS (TTM)
$-0.71
Dividend yield
—
52W range
$27 – $41
Volume
0.4M
Immunocore Holdings Ltd (IMCR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |